IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 366 filers reported holding IONIS PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 1.27 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $722 | +8.6% | 15,919 | -1.7% | 0.00% | 0.0% |
| Q2 2023 | $665 | +15.7% | 16,198 | +0.8% | 0.00% | 0.0% |
| Q1 2023 | $575 | -6.0% | 16,076 | -0.8% | 0.00% | 0.0% |
| Q4 2022 | $612 | -99.9% | 16,203 | +2.4% | 0.00% | -33.3% |
| Q3 2022 | $700,000 | +19.5% | 15,818 | -0.1% | 0.00% | 0.0% |
| Q2 2022 | $586,000 | -0.2% | 15,830 | -0.2% | 0.00% | +50.0% |
| Q1 2022 | $587,000 | +21.3% | 15,861 | -0.2% | 0.00% | 0.0% |
| Q4 2021 | $484,000 | -18.7% | 15,895 | -10.3% | 0.00% | 0.0% |
| Q3 2021 | $595,000 | -20.9% | 17,728 | -6.0% | 0.00% | -50.0% |
| Q2 2021 | $752,000 | -18.8% | 18,864 | -8.4% | 0.00% | -20.0% |
| Q1 2021 | $926,000 | -35.6% | 20,604 | -19.0% | 0.01% | -37.5% |
| Q4 2020 | $1,437,000 | -81.6% | 25,423 | -84.5% | 0.01% | -83.7% |
| Q3 2020 | $7,797,000 | -21.1% | 164,321 | -1.9% | 0.05% | -25.8% |
| Q2 2020 | $9,876,000 | +49.5% | 167,506 | +19.9% | 0.07% | +22.2% |
| Q1 2020 | $6,605,000 | -21.3% | 139,707 | +0.6% | 0.05% | -8.5% |
| Q4 2019 | $8,390,000 | +13.5% | 138,882 | +12.6% | 0.06% | 0.0% |
| Q3 2019 | $7,392,000 | -5.1% | 123,386 | +1.8% | 0.06% | -7.8% |
| Q2 2019 | $7,790,000 | -9.9% | 121,204 | +13.8% | 0.06% | -15.8% |
| Q1 2019 | $8,646,000 | -27.7% | 106,523 | -51.8% | 0.08% | +28.8% |
| Q4 2018 | $11,956,000 | +106.9% | 221,176 | +97.4% | 0.06% | +15.7% |
| Q3 2018 | $5,779,000 | -44.0% | 112,057 | -54.8% | 0.05% | +4.1% |
| Q2 2018 | $10,320,000 | +77.5% | 247,702 | +87.8% | 0.05% | -14.0% |
| Q1 2018 | $5,814,000 | -9.4% | 131,896 | +3.4% | 0.06% | -12.3% |
| Q4 2017 | $6,418,000 | -0.1% | 127,596 | +0.6% | 0.06% | -4.4% |
| Q3 2017 | $6,427,000 | -2.8% | 126,774 | -2.5% | 0.07% | -5.6% |
| Q2 2017 | $6,614,000 | +28.2% | 130,015 | +1.3% | 0.07% | +26.3% |
| Q1 2017 | $5,161,000 | -18.9% | 128,379 | -3.5% | 0.06% | -25.0% |
| Q4 2016 | $6,361,000 | +90.2% | 133,000 | +45.7% | 0.08% | +76.7% |
| Q3 2016 | $3,344,000 | +47.3% | 91,255 | -6.4% | 0.04% | +38.7% |
| Q2 2016 | $2,270,000 | -30.3% | 97,485 | +21.1% | 0.03% | -36.7% |
| Q1 2016 | $3,259,000 | +6.8% | 80,476 | +63.3% | 0.05% | -2.0% |
| Q4 2015 | $3,051,000 | – | 49,270 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,541,136 | $133,749 | 7.12% |
| Bellevue Group AG | 9,743,900 | $368,027,103 | 4.88% |
| M28 Capital Management LP | 126,300 | $4,770,351 | 4.55% |
| Sicart Associates LLC | 246,258 | $9,301,165 | 3.28% |
| Camber Capital Management LP | 1,925,000 | $72,707 | 2.49% |
| Privium Fund Management B.V. | 148,807 | $5,557,941 | 2.11% |
| Deep Track Capital, LP | 1,205,773 | $45,542,046 | 1.91% |
| BVF INC/IL | 1,121,809 | $42,370,726 | 1.79% |
| Orbimed Advisors | 1,993,600 | $75,298,272 | 1.44% |
| Parkman Healthcare Partners LLC | 141,115 | $5,329,914 | 1.42% |